NCT01562431View on ClinicalTrials.gov

The Signal-Trial: Evaluation of a Screening Tool for Psychosocial Problems in Cancer Genetics

NACompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

June 30, 2013

Conditions
Psychosocial IssuesCancer Genetics
Interventions
OTHER

Feed-back

Counselors will receive the results of the completed Signal-checklist completed by participants in the intervention group

Trial Locations (1)

1066 cx

Netherlands Cancer Institute, Amsterdam

All Listed Sponsors
collaborator

UMC Utrecht

OTHER

lead

The Netherlands Cancer Institute

OTHER

NCT01562431 - The Signal-Trial: Evaluation of a Screening Tool for Psychosocial Problems in Cancer Genetics | Biotech Hunter | Biotech Hunter